Allergan (AGN): Buy Into The Weakness - Cowen

September 22, 2017 6:34 AM EDT Send to a Friend
Cowen analyst, Ken Cacciatore, reiterated his Outperform rating on shares of Allergen (NYSE: AGN) noting that multiple issues have caused ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login